390 related articles for article (PubMed ID: 27537822)
1. Tinea and Onychomycosis.
Rosen T
Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S110-3. PubMed ID: 27537822
[TBL] [Abstract][Full Text] [Related]
2. Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
Markinson B; Caldwell B
J Am Podiatr Med Assoc; 2015 Sep; 105(5):407-11. PubMed ID: 26429609
[TBL] [Abstract][Full Text] [Related]
3. Management of onychomycosis and co-existing tinea pedis.
Lipner SR; Scher RK
J Drugs Dermatol; 2015 May; 14(5):492-4. PubMed ID: 25942668
[TBL] [Abstract][Full Text] [Related]
4. What is new in fungal pharmacotherapeutics?
Routt ET; Jim SC; Zeichner JA; Kircik LH
J Drugs Dermatol; 2014 Apr; 13(4):391-5; quiz 396. PubMed ID: 24719057
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
Kawai M
Med Mycol J; 2019; 60(3):71-74. PubMed ID: 31474693
[TBL] [Abstract][Full Text] [Related]
6. Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis.
Gupta AK; Studholme C
Skin Therapy Lett; 2016 Nov; 21(6):7-11. PubMed ID: 27825175
[TBL] [Abstract][Full Text] [Related]
7. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ciclopiroxolamine 1% cream in onychomycosis and tinea pedis.
Wu YC; Chuan MT; Lü YC
Mycoses; 1991; 34(1-2):93-5. PubMed ID: 1833642
[TBL] [Abstract][Full Text] [Related]
9. Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis.
Koga H; Nanjoh Y; Kaneda H; Yamaguchi H; Tsuboi R
Antimicrob Agents Chemother; 2012 Jun; 56(6):3138-43. PubMed ID: 22391525
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
Watanabe S; Kishida H; Okubo A
J Dermatol; 2017 Jul; 44(7):753-759. PubMed ID: 28332720
[TBL] [Abstract][Full Text] [Related]
12. Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis.
Del Rosso JQ
J Am Osteopath Assoc; 1997 Jun; 97(6):339-46. PubMed ID: 9232944
[TBL] [Abstract][Full Text] [Related]
13. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
Del Rosso JQ
J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929
[TBL] [Abstract][Full Text] [Related]
14. Topical antifungal drugs in the treatment of tinea pedis, tinea cruris, and tinea corporis.
Smith EB
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):S24-S28. PubMed ID: 8496408
[TBL] [Abstract][Full Text] [Related]
15. Tavaborole, Efinaconazole, and Luliconazole: Three New Antimycotic Agents for the Treatment of Dermatophytic Fungi.
Saunders J; Maki K; Koski R; Nybo SE
J Pharm Pract; 2017 Dec; 30(6):621-630. PubMed ID: 27488125
[TBL] [Abstract][Full Text] [Related]
16. Onychomycosis: Strategies to Minimize Recurrence.
Gupta AK; Elewski BE; Rosen T; Caldwell B; Pariser DM; Kircik LH; Bhatia N; Tosti A
J Drugs Dermatol; 2016 Mar; 15(3):279-82. PubMed ID: 26954312
[TBL] [Abstract][Full Text] [Related]
17. Once-daily luliconazole cream 1% for the treatment of interdigital tinea pedis.
Gold MH; Olin JT
Expert Rev Anti Infect Ther; 2015; 13(12):1433-40. PubMed ID: 26559086
[TBL] [Abstract][Full Text] [Related]
18. Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview.
Doncker PD; Gupta AK; Marynissen G; Stoffels P; Heremans A
J Am Acad Dermatol; 1997 Dec; 37(6):969-74. PubMed ID: 9418766
[TBL] [Abstract][Full Text] [Related]
19. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
[TBL] [Abstract][Full Text] [Related]
20. Current treatment of dermatophytoses.
Hay RJ
Acta Derm Venereol Suppl (Stockh); 1986; 121():117-23. PubMed ID: 2940791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
